Co-Authors
This is a "connection" page, showing publications co-authored by David Cognetti and Tingting Zhan.
Connection Strength
1.393
-
Mastrolonardo E, Stewart M, Alapati R, Campbell D, Thaler A, Zhan T, Curry JM, Luginbuhl AJ, Cognetti DM. Improved efficiency of sialendoscopy procedures at an ambulatory surgery center. Am J Otolaryngol. 2021 May-Jun; 42(3):102927.
Score: 0.231
-
Mastrolonardo E, Stewart M, Alapati R, Thaler A, Zhan T, Curry JM, Luginbuhl AJ, Cognetti DM. Comparison of general anesthesia and monitored anesthesia care for sialendoscopy procedures. Am J Otolaryngol. 2021 Jan - Feb; 42(1):102809.
Score: 0.227
-
Dang S, Duffy A, Li JC, Gandee Z, Rana T, Gunville B, Zhan T, Curry J, Luginbuhl A, Cottrill E, Cognetti D. Postoperative opioid-prescribing practices in otolaryngology: A multiphasic study. Laryngoscope. 2019 Jun 21.
Score: 0.207
-
Cognetti DM, Nussenbaum B, Brenner MJ, Chi DH, McCormick ME, Venkatraman G, Zhan T, McKinlay AJ. Current State of Overlapping, Concurrent, and Multiple-Room Surgery in Otolaryngology: A National Survey. Otolaryngol Head Neck Surg. 2017 Aug 01; 194599817723897.
Score: 0.182
-
Luginbuhl A, Calder A, Kutler D, Zender C, Wise-Draper T, Patel J, Cheng M, Karivedu V, Zhan T, Parashar B, Gulati S, Yao M, Lavertu P, Takiar V, Tang A, Johnson J, Keane W, Curry J, Cognetti D, Bar-Ad V. Multi-Institutional Study Validates Safety of Intraoperative Cesium-131 Brachytherapy for Treatment of Recurrent Head and Neck Cancer. Front Oncol. 2021; 11:786216.
Score: 0.061
-
Stewart M, Mastrolonardo E, Ghias A, Butkus J, Hobelmann K, Zhan T, Dang S, Cognetti D, Rosen D, Boon M, Huntley C. Opioid Usage and Pain Control in Benign Oropharyngeal Surgery: An Observational Prospective Study. Ann Otol Rhinol Laryngol. 2021 Oct 25; 34894211053290.
Score: 0.061
-
Stewart M, Butkus J, Mastrolonardo E, Banoub R, Zhan T, Dang S, Cognetti D, Chiffer R, Willcox T. Otologic opioid usage and pain control in the postoperative period: An observational prospective study. Am J Otolaryngol. 2021 Sep 02; 43(1):103191.
Score: 0.060
-
Amin D, Richa T, Mollaee M, Zhan T, Tassone P, Johnson J, Luginbuhl A, Cognetti D, Martinez-Outschoorn U, Stapp R, Solomides C, Rodeck U, Curry J. Metformin effects on FOXP3+ and CD8+ T cell infiltrates of head and neck squamous cell carcinoma. Laryngoscope. 2019 Oct 08.
Score: 0.053
-
Vimawala S, Topf MC, Savard C, Zhan T, Keane W, Luginbuhl A, Goldman R, Cognetti DM, Curry JM. Risk factors for unplanned readmission in total laryngectomy patients. Laryngoscope. 2019 Aug 26.
Score: 0.052
-
Curry JM, Johnson J, Mollaee M, Tassone P, Amin D, Knops A, Whitaker-Menezes D, Mahoney MG, South A, Rodeck U, Zhan T, Harshyne L, Philp N, Luginbuhl A, Cognetti D, Tuluc M, Martinez-Outschoorn U. Metformin Clinical Trial in HPV+ and HPV- Head and Neck Squamous Cell Carcinoma: Impact on Cancer Cell Apoptosis and Immune Infiltrate. Front Oncol. 2018; 8:436.
Score: 0.049
-
Tassone P, Crawley M, Bovenzi C, Zhan T, Keane W, Cognetti D, Luginbuhl A, Curry J. Pathologic Markers in Surgically Treated HPV-Associated Oropharyngeal Cancer: Retrospective Study, Systematic Review, and Meta-analysis. Ann Otol Rhinol Laryngol. 2017 May; 126(5):365-374.
Score: 0.044
-
Curry J, Johnson J, Tassone P, Vidal MD, Menezes DW, Sprandio J, Mollaee M, Cotzia P, Birbe R, Lin Z, Gill K, Duddy E, Zhan T, Leiby B, Reyzer M, Cognetti D, Luginbuhl A, Tuluc M, Martinez-Outschoorn U. Metformin effects on head and neck squamous carcinoma microenvironment: Window of opportunity trial. Laryngoscope. 2017 Feb 10.
Score: 0.044
-
Curry JM, Tassone P, Cotzia P, Sprandio J, Luginbuhl A, Cognetti DM, Mollaee M, Domingo-Vidal M, Pribitkin EA, Keane WM, Zhan T, Birbe R, Tuluc M, Martinez-Outschoorn U. Multicompartment metabolism in papillary thyroid cancer. Laryngoscope. 2016 Oct; 126(10):2410-8.
Score: 0.041
-
Bovenzi CD, Hamilton J, Tassone P, Johnson J, Cognetti DM, Luginbuhl A, Keane WM, Zhan T, Tuluc M, Bar-Ad V, Martinez-Outschoorn U, Curry JM. Prognostic Indications of Elevated MCT4 and CD147 across Cancer Types: A Meta-Analysis. Biomed Res Int. 2015; 2015:242437.
Score: 0.041
-
Johnson JM, Lai SY, Cotzia P, Cognetti D, Luginbuhl A, Pribitkin EA, Zhan T, Mollaee M, Domingo-Vidal M, Chen Y, Campling B, Bar-Ad V, Birbe R, Tuluc M, Martinez Outschoorn U, Curry J. Mitochondrial Metabolism as a Treatment Target in Anaplastic Thyroid Cancer. Semin Oncol. 2015 Dec; 42(6):915-22.
Score: 0.040